Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1953 1
1961 1
1969 1
1975 1
1977 1
1978 2
1981 1
1982 1
1983 1
1984 1
1985 1
1986 1
1987 1
1988 2
1989 1
1990 3
1991 9
1992 3
1993 5
1994 3
1995 4
1996 2
1997 2
1999 1
2000 4
2001 3
2002 7
2003 4
2004 7
2005 2
2006 8
2007 8
2008 13
2009 9
2010 11
2011 16
2012 26
2013 15
2014 10
2015 9
2016 15
2017 13
2018 23
2019 30
2020 26
2021 49
2022 37
2023 50
2024 43
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
Borchert RJ, Azevedo T, Badhwar A, Bernal J, Betts M, Bruffaerts R, Burkhart MC, Dewachter I, Gellersen HM, Low A, Lourida I, Machado L, Madan CR, Malpetti M, Mejia J, Michopoulou S, Muñoz-Neira C, Pepys J, Peres M, Phillips V, Ramanan S, Tamburin S, Tantiangco HM, Thakur L, Tomassini A, Vipin A, Tang E, Newby D; Deep Dementia Phenotyping (DEMON) Network; Ranson JM, Llewellyn DJ, Veldsman M, Rittman T. Borchert RJ, et al. Among authors: mejia j. Alzheimers Dement. 2023 Dec;19(12):5885-5904. doi: 10.1002/alz.13412. Epub 2023 Aug 10. Alzheimers Dement. 2023. PMID: 37563912 Review.
General care in the management of severe traumatic brain injury: Latin American consensus.
Godoy DA, Videtta W, Santa Cruz R, Silva X, Aguilera-Rodríguez S, Carreño-Rodríguez JN, Ciccioli F, Piñero G, Ciro JD, da Re-Gutiérrez S, Domeniconi G, Fischer D, Hernández O, Lacerda-Gallardo A, Mejía J, Panhke P, Romero C, Lora FS, Soler-Morejón C, Sufan JL, Montes JM, Fuenzalida LC, Parahnos JL, Jibaja M; en representación del Consorcio Latinoamericano de Injuria Cerebral (LABIC). Godoy DA, et al. Among authors: mejia j. Med Intensiva (Engl Ed). 2020 Nov;44(8):500-508. doi: 10.1016/j.medin.2020.01.014. Epub 2020 May 4. Med Intensiva (Engl Ed). 2020. PMID: 32376092 English, Spanish.
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
Winer EP, Lipatov O, Im SA, Goncalves A, Muñoz-Couselo E, Lee KS, Schmid P, Tamura K, Testa L, Witzel I, Ohtani S, Turner N, Zambelli S, Harbeck N, Andre F, Dent R, Zhou X, Karantza V, Mejia J, Cortes J; KEYNOTE-119 investigators. Winer EP, et al. Among authors: mejia j. Lancet Oncol. 2021 Apr;22(4):499-511. doi: 10.1016/S1470-2045(20)30754-3. Epub 2021 Mar 4. Lancet Oncol. 2021. PMID: 33676601 Clinical Trial.
440 results